SCHEMBL27355672

SCHEMBL27355672

CCCCCCCCCC(=O)OCC(CCCCN(CCO)CCCCC(COC(=O)CCCCCCCCC)(COC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC)(COC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.46
DGKA P23743 1/20 0.45
PAM P19021 2/20 0.42
LMNA P02545 2/20 0.41
KDM4E B2RXH2 1/20 0.41
DUSP3 P51452 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPT P10636 2/20 0.40
TSHR P16473 1/20 0.40
PRKCA P17252 3/20 0.40
PRKCE Q02156 1/20 0.40
PRKCQ Q04759 1/20 0.40
PRKCD Q05655 1/20 0.40
ALDH1A1 P00352 1/20 0.39
KDM5A P29375 2/20 0.39
PHF8 Q9UPP1 2/20 0.39
KDM4C Q9H3R0 1/20 0.39
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29343911 0.90 DNM1 (0.47) DNM1DGKAPAMLMNAKDM4E
SCHEMBL29343890 0.86 DNM1 (0.48) DNM1DGKAPAMLMNAKDM4E
SCHEMBL18328047 0.85 DGKA (0.60) DNM1DGKAPAMLMNAKDM4E
SCHEMBL18328046 0.85 DGKA (0.60) DNM1DGKAPAMLMNAKDM4E
SCHEMBL18328045 0.85 DGKA (0.60) DNM1DGKAPAMLMNAKDM4E
SCHEMBL13616522 0.84 DGKA (0.51) DNM1DGKAPAMLMNAKDM4E
SCHEMBL30714409 0.83 DNM1 (0.44) DNM1DGKAPAMLMNAKDM4E
SCHEMBL20522877 0.82 DGKA (0.60) DNM1DGKAPAMLMNAKDM4E
SCHEMBL20892180 0.81 DGKA (0.61) DNM1DGKAPAMLMNAKDM4E
SCHEMBL21842816 0.81 DGKA (0.61) DNM1DGKAPAMLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023201097-A1 METHODS AND COMPOSITIONS FOR IMMUNE CELL REJUVENATION AND THERAPIES USING REJUVENATED IMMUNE CELLS TURN BIOTECHNOLOGIES, INC. (US) 2023-10-19 WO disclosed